Vidglit Tablet is a medication specifically designed to manage type 2 diabetes mellitus, a condition characterized by high blood sugar levels. It is recommended for individuals who have difficulty controlling their blood sugar through diet and exercise alone. This tablet is formulated to work in conjunction with a healthy diet and regular physical activity to regulate blood sugar levels effectively, reducing the risk of severe diabetes-related complications such as kidney damage and vision problems.

For those prescribed Vidglit Tablet, it is essential to adhere to the prescribed dosage and timing as instructed by the healthcare provider. Consistency in taking the medication at the same time each day is crucial to derive maximum benefits. It is advised not to discontinue the medication without consulting the doctor, as Vidglit Tablet plays a significant role in managing blood sugar levels and preventing potential complications in the future.

The active ingredient in Vidglit Tablet, Teneligliptin, falls under the category of dipeptidyl peptidase-4 (DPP-4) inhibitors. This component functions by inhibiting the action of the enzyme DPP-4, which otherwise breaks down the hormone 'Incretin.' By blocking this enzyme, Vidglit Tablet helps in orchestrating insulin production as needed and lowering blood sugar levels by reducing liver glucose output when not necessary.

It is essential to be aware of potential side effects associated with Vidglit Tablet, such as hypoglycemia, constipation, dizziness, and headaches. Individuals taking this medication should be mindful of symptoms of hypoglycemia and take necessary precautions. If side effects persist or cause concern, contacting the doctor for guidance is recommended.

Before initiating treatment with Vidglit Tablet, individuals should disclose their medical history, including any kidney, heart, or pancreas issues, to the healthcare provider. Pregnant or breastfeeding individuals should also seek medical advice before using this medication. It is crucial to inform the doctor about all concurrently used medications to avoid potential interactions. Regular monitoring of kidney function and blood glucose levels may be necessary to ensure the medication's effectiveness.

Vidglit Tablet, containing Teneligliptin, is a medication classified as a DPP-4 inhibitor and is beneficial in the treatment of Type 2 diabetes mellitus. By stimulating the production of insulin in the body after meals and regulating the release of glucose into the bloodstream, Vidglit Tablet effectively lowers blood glucose levels. This is crucial in managing diabetes and reducing the risk of severe complications such as kidney damage, vision impairment, and limb amputation associated with uncontrolled diabetes. Additionally, maintaining proper blood sugar levels through the use of Vidglit Tablet can lower the chances of developing heart disease and stroke.

The mechanism of action of Vidglit Tablet involves blocking the enzyme DPP-4, which is responsible for breaking down the hormone 'Incretin'. By preserving Incretin, the medication ensures that insulin is produced only as needed and prevents the liver from releasing excessive glucose into the blood. It is essential to note that Vidglit Tablet is not suitable for individuals with type 1 diabetes or those experiencing diabetic ketoacidosis.

Overall, incorporating Vidglit Tablet into a diabetes management regimen, including a balanced diet and regular exercise, is crucial for leading a healthy and normal life. Consistent use of this medication as prescribed by healthcare providers can significantly contribute to controlling blood sugar levels, preventing diabetic complications such as retinopathy, nephropathy, neuropathy, diabetic foot ulcers, and delayed wound healing. By prioritizing proper blood glucose regulation with the help of Vidglit Tablet, individuals can enhance their quality of life and reduce the risks associated with unmanaged diabetes.

To properly use Vidglit Tablet, it is important to follow the directions provided by your doctor. Take the medicine in the exact dose and duration as prescribed. Swallow the tablet whole with a glass of water, without chewing, crushing, or breaking it. While you can take Vidglit Tablet with or without food, it is recommended to take it at the same time each day for better effectiveness. If you experience stomach upset, it is advised to take the tablet with a meal to minimize any discomfort, following the guidance of your doctor. By following these instructions, you can ensure that you are using Vidglit Tablet correctly and maximizing its potential benefits for your health.

The Vidglit Tablet is mainly used in the treatment of Type 2 diabetes mellitus. This medication is specifically designed to help manage and control blood sugar levels in individuals with this type of diabetes. By regulating blood sugar, the Vidglit Tablet aids in reducing the symptoms and complications associated with Type 2 diabetes mellitus. This makes it a crucial part of the overall treatment plan for individuals living with this condition.

Vidglit Tablet is commonly used for managing Type 2 Diabetes. This condition arises when the body cannot produce enough insulin or when the insulin produced is not effectively used. This leads to high blood sugar levels. Symptoms of Type 2 diabetes include increased thirst, frequent urination, slow wound healing, increased hunger, fatigue, and blurred vision. Complications that may arise from untreated Type 2 diabetes include nerve problems, kidney problems, eye damage, limb amputation, sexual dysfunction, and an increased risk of heart attack or stroke.

If you experience symptoms of hypoglycemia, such as lightheadedness, sweating, dizziness, fainting, or dry mouth, it is important to seek medical help immediately. These are signs of low blood sugar levels that need prompt attention. Additionally, if you have persistent side effects like constipation, dizziness, headache, or diarrhea that do not go away or concern you, consult your doctor. It's crucial to inform your doctor if you have a history of kidney disease, heart disease, or pancreas problems before taking Vidglit Tablet. Pregnant or breastfeeding women should also seek advice from their healthcare provider prior to starting this medication. Moreover, if you notice any unusual changes in your body temperature or have any other health concerns while taking Vidglit Tablet, do not hesitate to reach out to your doctor. Regular monitoring through kidney function and blood glucose level tests is essential to ensure the medicine is working effectively. Remember to limit alcohol intake to reduce the risk of low blood sugar levels. Your doctor is your best source of guidance and support in managing your diabetes effectively.

Vidglit Tablet may cause certain side effects, although most of them are generally mild and should go away as your body gets used to the medication. However, if any of these side effects persist or concern you, it's important to talk to your doctor. Some common side effects of Vidglit Tablet include hypoglycemia (low blood glucose level), constipation, dizziness, headache, diarrhea, and increased body temperature. In addition, other possible side effects may include headaches, low blood glucose levels, upper respiratory tract infections, and nasopharyngitis which is an infection of the nose and throat often associated with the common cold. If you experience any of these side effects, consult your healthcare provider for guidance.

Before consuming Vidglit Tablet, it is important to note certain precautions. Do not take Vidglit Tablet if you have an allergy to it or any of its components. If you are pregnant or breastfeeding, consult your doctor prior to using Vidglit Tablet. It is not recommended for use in children since its safety and effectiveness in this group are not established. Long-term use of Vidglit Tablet can lead to acute pancreatitis, and combining it with other anti-diabetic medications or insulin may increase the risk of hypoglycemia. If such combination is necessary, your doctor may adjust the dosage. Some individuals may experience severe allergic reactions such as anaphylaxis, skin swelling, or skin conditions while taking Vidglit Tablet. Individuals with type 1 diabetes or diabetic ketoacidosis should avoid using Vidglit Tablet.

If you forget to take a dose of Vidglit Tablet, try to take it as soon as you remember. But, if it's nearly time for your next scheduled dose, it's better to skip the missed dose and continue with your normal dosing routine. Avoid taking a double dose to make up for the missed one. It is important to follow the prescribed dosing schedule for Vidglit Tablet to ensure its effectiveness.

When starting a new medication like Vidglit Tablet, it is important to monitor certain lab tests to ensure that the treatment is effective and safe for you. The related lab tests for Vidglit Tablet include:

1. Glucose - Fasting Blood Test: This test measures the amount of glucose in your blood after you have not eaten for at least 8 hours. It helps to evaluate your fasting blood sugar levels and detect any potential issues with your body's ability to regulate blood sugar.

2. Glucose - Postprandial Blood Test: This test measures the amount of glucose in your blood 2 hours after a meal. It helps to assess how your body processes glucose after eating and can provide important insights into your insulin sensitivity and overall blood sugar control.

3. Glycosylated Hemoglobin (HbA1c) Test: This test measures the average blood sugar levels over the past 2-3 months by assessing the amount of glucose that is bound to hemoglobin in red blood cells. It is a crucial indicator of long-term blood sugar control and can help in managing diabetes effectively.

By regularly monitoring these related lab tests as advised by your healthcare provider, you can track your response to Vidglit Tablet treatment and make necessary adjustments to ensure optimal health outcomes.